Primary Invasive Vaginal Cancer in the Setting of the Mayer–Rokitansky–Kuster–Hauser Syndrome

Background. The Mayer–Rokitansky–Kuster–Hauser syndrome occurs in 1 in 4000 to 5000 female births. Primary vaginal cancer constitutes less than 2% of all malignancies of the female genital tract. A report of the first case of the unlikely occurrence of both of these developments in the same patient...

Full description

Saved in:
Bibliographic Details
Published inGynecologic oncology Vol. 85; no. 2; pp. 384 - 387
Main Authors Tewari, Devansu S., McHale, Michael T., Kuo, Jeffrey V., Monk, Bradley J., Burger, Robert A.
Format Journal Article
LanguageEnglish
Published San Diego, CA Elsevier Inc 01.05.2002
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background. The Mayer–Rokitansky–Kuster–Hauser syndrome occurs in 1 in 4000 to 5000 female births. Primary vaginal cancer constitutes less than 2% of all malignancies of the female genital tract. A report of the first case of the unlikely occurrence of both of these developments in the same patient is presented. Case. A 34-year-old nulligravid Philippine woman with a history of Mayer–Rokitansky–Kuster–Hauser syndrome presented with a 5-month history of bleeding from a blind vaginal pouch. Vaginal biopsy identified a moderately differentiated endometrioid adenocarcinoma. Exploratory laparotomy, bilateral salpingo-oophorectomy, pelvic and iliac lymph node samplings, and excision of a mullerian remnant were performed with no evidence of disease. A FIGO Stage I vaginal cancer was assigned and pelvic irradiation was given. Disease recurred 4 months later and the patient underwent total pelvic exenteration. More than 1 year since the exenteration procedure, she is without evidence of disease. Conclusion. This is the first reported case of a primary vaginal cancer in a patient with Mayer–Rokitansky–Kuster–Hauser syndrome. It is a reminder that routine gynecologic examinations are still warranted as these patients are at risk for malignant changes in residual mullerian tissues.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0090-8258
1095-6859
DOI:10.1006/gyno.2002.6637